QIAGEN N.V.
QGENNYSEHealthcare · Biological Products, (No Diagnostic Substances) · P7 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Wellington Management Group LlpPassive (13G)Feb 10, 2026
- Blackrock, Inc.Passive (13G)Feb 6, 2026
- Massachusetts Financial Services Co /Ma/Passive (13G)May 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 9.1M | 4.0 | +42.9% |
| Apr 30, 2026 | 6.4M | 2.5 | +9.3% |
| Apr 15, 2026 | 5.8M | 4.3 | -1.7% |
| Mar 31, 2026 | 5.9M | 3.3 | -3.4% |
| Mar 13, 2026 | 6.1M | 2.4 | -10.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- SDJun 1, 2026
- 6-KMay 8, 2026
- 6-KMay 8, 2026
- 6-KMay 1, 2026
- IRANNOTICEMar 20, 2026
- 20-FMar 20, 2026
- SCHEDULE 13G/AFeb 10, 2026
- SCHEDULE 13GFeb 6, 2026
- 6-KFeb 6, 2026
- 25-NSE/AJan 9, 2026
- 25-NSEJan 8, 2026
- 6-KDec 22, 2025
- SCHEDULE 13G/ANov 12, 2025
- 6-KNov 6, 2025
- 6-KNov 6, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.